HLA-DR antibody
Quick Overview for HLA-DR antibody (ABIN2704364)
Target
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
- 
    - 
                                            Purpose
- Anti-HLA-DR Unconjugated Antibody
- 
                                            Characteristics
- The L243 reacts with human HLA-DR antigen which is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes, activated natural killer (NK) lymphocytes, and human progenitor cells. HLA-DR is also present on thymic epithelium, B lymphocyte dependent areas of spleen and lymph node, and B cell lymphomas.
- 
                                            Purification
- Purified
- 
                                            Purity
- >95 %
- 
                                            Immunogen
- Human B lymphocytes
- 
                                            Isotype
- IgG2a, kappa
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working dilution should be determined by the investigator.
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- 0.5 mg/mL
- 
                                            Buffer
- PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- 4 °C
 
- 
                                            
- 
    - HLA-DR
- 
                                            Alternative Name
- HLA-DR
- 
                                            Gene ID
- 3122, 3123
- 
                                            NCBI Accession
- NM_019111
- 
                                            UniProt
- P01903
- 
                                            Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
 Target
- 
                    
 
                                     
                                     
                                    